Project Details
Short title | A Phase 2a trial of Avelumab, an anti-PDL 1 antibody, in relapsed and refractory peripheral T-cell lymphoma (AVAIL-T) |
---|---|
Status | Active |
Effective start/end date | 6/07/17 → 31/12/25 |
Funding
- PFIZER LIMITED
Short title | A Phase 2a trial of Avelumab, an anti-PDL 1 antibody, in relapsed and refractory peripheral T-cell lymphoma (AVAIL-T) |
---|---|
Status | Active |
Effective start/end date | 6/07/17 → 31/12/25 |